{
    "abstract": "Bexsero, a new vaccine against serogroup B meningococcal disease (MenB), was licensed in Europe in January 2013. In Germany, Bexsero is recommended for persons at increased risk of invasive meningococcal disease, but not for universal childhood vaccination. To support decision making we adapted the independently developed model for England to the German setting to predict the potential health impact and cost-effectiveness of universal vaccination with Bexsero\u00ae against MenB disease. We used both cohort and transmission dynamic mathematical models, the latter allowing for herd effects, to consider the impact of vaccination on individuals aged 0\u201399 years. Vaccination strategies included infant and adolescent vaccination, alone or in combination, and with one-off catch-up programmes. German specific data were used where possible from routine surveillance data and the literature. We assessed the impact of vaccination through cases averted and quality adjusted life years (QALY) gained and calculated costs per QALY gained. Assuming 65% vaccine uptake and 82% strain coverage, infant vaccination was estimated to prevent 15% (34) of MenB cases over the lifetime of one birth cohort. Including herd effects from vaccination increased the cases averted by infant vaccination to 22%, with an estimated 8461 infants requiring vaccination to prevent one case. In the short term the greatest health benefit is achieved through routine infant vaccination with large-scale catch-up, which could reduce cases by 24.9% after 5 years and 27.9% after 10 years. In the long term (20+ years) policies including routine adolescent vaccination are most favourable if herd effects are assumed. Under base case assumptions with a vaccine list price of \u20ac96.96 the incremental cost-effectiveness ratio (ICER) was >\u20ac500,000 per QALY for all considered strategies. Given the current very low incidence of MenB disease in Germany, universal vaccination with Bexsero\u00ae would prevent only a small absolute number of cases, at a high overall cost.",
    "author_highlights": [
        {
            "endOffset": 14464,
            "sentence": "We modelled the potential impact of vaccination against MenB disease in Germany.",
            "startOffset": 14384
        },
        {
            "endOffset": 14544,
            "sentence": "Without herd effects, predicted MenB cases averted through vaccination are low.",
            "startOffset": 14465
        },
        {
            "endOffset": 14626,
            "sentence": "With herd effects, adolescent vaccination provides the best long-term protection.",
            "startOffset": 14545
        },
        {
            "endOffset": 14709,
            "sentence": "All base case strategies had incremental cost-effectiveness ratios >\u20ac500,000/QALY.",
            "startOffset": 14627
        }
    ],
    "bib_entries": {
        "bib0190": {
            "authors": [
                {
                    "first": "Russell M.",
                    "initial": "R.M.",
                    "last": "Viner"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Booy"
                },
                {
                    "first": "Helen",
                    "initial": "H.",
                    "last": "Johnson"
                },
                {
                    "first": "W. John",
                    "initial": "W.J.",
                    "last": "Edmunds"
                },
                {
                    "first": "Lee",
                    "initial": "L.",
                    "last": "Hudson"
                },
                {
                    "first": "Helen",
                    "initial": "H.",
                    "last": "Bedford"
                },
                {
                    "first": "Ed",
                    "initial": "E.",
                    "last": "Kaczmarski"
                },
                {
                    "first": "Kaukab",
                    "initial": "K.",
                    "last": "Rajput"
                },
                {
                    "first": "Mary",
                    "initial": "M.",
                    "last": "Ramsay"
                },
                {
                    "first": "Deborah",
                    "initial": "D.",
                    "last": "Christie"
                }
            ],
            "doi": "10.1016/S1474-4422(12)70180-1",
            "firstpage": "774",
            "issn": "14744422",
            "lastpage": "783",
            "pmid": "22863608",
            "pub_year": 2012,
            "title": "Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): A case-control study",
            "volume": "11"
        },
        "bib0195": null,
        "bib0200": {
            "authors": [
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Wiese-Posselt"
                },
                {
                    "first": "W.",
                    "initial": "W.",
                    "last": "Hellenbrand"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Siedler"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Mayer"
                }
            ],
            "firstpage": "E060907.4",
            "issn": "15607917",
            "pmid": "17075143",
            "pub_year": 2006,
            "title": "Universal childhood immunisation with pneumococcal vaccine and meningococcal serogroup C vaccine introduced in Germany.",
            "volume": "11"
        },
        "bib0205": {
            "authors": [
                {
                    "first": "Wiebke",
                    "initial": "W.",
                    "last": "Hellenbrand"
                },
                {
                    "first": "Johannes",
                    "initial": "J.",
                    "last": "Elias"
                },
                {
                    "first": "Ole",
                    "initial": "O.",
                    "last": "Wichmann"
                },
                {
                    "first": "Manuel",
                    "initial": "M.",
                    "last": "Dehnert"
                },
                {
                    "first": "Matthias",
                    "initial": "M.",
                    "last": "Frosch"
                },
                {
                    "first": "Ulrich",
                    "initial": "U.",
                    "last": "Vogel"
                }
            ],
            "doi": "10.1016/j.jinf.2012.09.008",
            "firstpage": "48",
            "issn": "01634453",
            "lastpage": "56",
            "pmid": "23043893",
            "pub_year": 2013,
            "title": "Epidemiology of invasive meningococcal disease in Germany, 2002-2010, and impact of vaccination with meningococcal C conjugate vaccine",
            "volume": "66"
        },
        "bib0210": null,
        "bib0215": {
            "authors": [
                {
                    "first": "Ulrich",
                    "initial": "U.",
                    "last": "Vogel"
                },
                {
                    "first": "Muhamed Kheir",
                    "initial": "M.K.",
                    "last": "Taha"
                },
                {
                    "first": "Julio A.",
                    "initial": "J.A.",
                    "last": "Vazquez"
                },
                {
                    "first": "Jamie",
                    "initial": "J.",
                    "last": "Findlow"
                },
                {
                    "first": "Heike",
                    "initial": "H.",
                    "last": "Claus"
                },
                {
                    "first": "Paola",
                    "initial": "P.",
                    "last": "Stefanelli"
                },
                {
                    "first": "Dominique A.",
                    "initial": "D.A.",
                    "last": "Caugant"
                },
                {
                    "first": "Paula",
                    "initial": "P.",
                    "last": "Kriz"
                },
                {
                    "first": "Raquel",
                    "initial": "R.",
                    "last": "Abad"
                },
                {
                    "first": "Stefania",
                    "initial": "S.",
                    "last": "Bambini"
                },
                {
                    "first": "Anna",
                    "initial": "A.",
                    "last": "Carannante"
                },
                {
                    "first": "Ala Eddine",
                    "initial": "A.E.",
                    "last": "Deghmane"
                },
                {
                    "first": "Cecilia",
                    "initial": "C.",
                    "last": "Fazio"
                },
                {
                    "first": "Matthias",
                    "initial": "M.",
                    "last": "Frosch"
                },
                {
                    "first": "Giacomo",
                    "initial": "G.",
                    "last": "Frosi"
                },
                {
                    "first": "Stefanie",
                    "initial": "S.",
                    "last": "Gilchrist"
                },
                {
                    "first": "Marzia M.",
                    "initial": "M.M.",
                    "last": "Giuliani"
                },
                {
                    "first": "Eva",
                    "initial": "E.",
                    "last": "Hong"
                },
                {
                    "first": "Morgan",
                    "initial": "M.",
                    "last": "Ledroit"
                },
                {
                    "first": "Pietro G.",
                    "initial": "P.G.",
                    "last": "Lovaglio"
                },
                {
                    "first": "Jay",
                    "initial": "J.",
                    "last": "Lucidarme"
                },
                {
                    "first": "Martin",
                    "initial": "M.",
                    "last": "Musilek"
                },
                {
                    "first": "Alessandro",
                    "initial": "A.",
                    "last": "Muzzi"
                },
                {
                    "first": "Jan",
                    "initial": "J.",
                    "last": "Oksnes"
                },
                {
                    "first": "Fabio",
                    "initial": "F.",
                    "last": "Rigat"
                },
                {
                    "first": "Luca",
                    "initial": "L.",
                    "last": "Orlandi"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Stella"
                },
                {
                    "first": "Danielle",
                    "initial": "D.",
                    "last": "Thompson"
                },
                {
                    "first": "Mariagrazia",
                    "initial": "M.",
                    "last": "Pizza"
                },
                {
                    "first": "Rino",
                    "initial": "R.",
                    "last": "Rappuoli"
                },
                {
                    "first": "Davide",
                    "initial": "D.",
                    "last": "Serruto"
                },
                {
                    "first": "Maurizio",
                    "initial": "M.",
                    "last": "Comanducci"
                },
                {
                    "first": "Giuseppe",
                    "initial": "G.",
                    "last": "Boccadifuoco"
                },
                {
                    "first": "John J.",
                    "initial": "J.J.",
                    "last": "Donnelly"
                },
                {
                    "first": "Duccio",
                    "initial": "D.",
                    "last": "Medini"
                },
                {
                    "first": "Ray",
                    "initial": "R.",
                    "last": "Borrow"
                }
            ],
            "doi": "10.1016/S1473-3099(13)70006-9",
            "firstpage": "416",
            "issn": "14733099",
            "lastpage": "425",
            "pmid": "23414709",
            "pub_year": 2013,
            "title": "Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: A qualitative and quantitative assessment",
            "volume": "13"
        },
        "bib0220": null,
        "bib0225": {
            "authors": [
                {
                    "first": "Hannah",
                    "initial": "H.",
                    "last": "Christensen"
                },
                {
                    "first": "Matthew",
                    "initial": "M.",
                    "last": "Hickman"
                },
                {
                    "first": "W. John",
                    "initial": "W.J.",
                    "last": "Edmunds"
                },
                {
                    "first": "Caroline L.",
                    "initial": "C.L.",
                    "last": "Trotter"
                }
            ],
            "doi": "10.1016/j.vaccine.2013.03.034",
            "firstpage": "2638",
            "issn": "0264410X",
            "lastpage": "2646",
            "pmid": "23566946",
            "pub_year": 2013,
            "title": "Introducing vaccination against serogroup B meningococcal disease: An economic and mathematical modelling study of potential impact",
            "volume": "31"
        },
        "bib0230": {
            "authors": [
                {
                    "first": "Natalie G.",
                    "initial": "N.G.",
                    "last": "Martin"
                },
                {
                    "first": "Matthew D.",
                    "initial": "M.D.",
                    "last": "Snape"
                }
            ],
            "doi": "10.1586/14760584.2013.814862",
            "firstpage": "837",
            "issn": "14760584",
            "lastpage": "858",
            "pmid": "23984957",
            "pub_year": 2013,
            "title": "A multicomponent serogroup B meningococcal vaccine is licensed for use in Europe: What do we know, and what are we yet to learn?",
            "volume": "12"
        },
        "bib0235": {
            "authors": [
                {
                    "first": "C. L.",
                    "initial": "C.L.",
                    "last": "Trotter"
                },
                {
                    "first": "N. J.",
                    "initial": "N.J.",
                    "last": "Gay"
                },
                {
                    "first": "W. John",
                    "initial": "W.J.",
                    "last": "Edmunds"
                }
            ],
            "doi": "10.1017/S0950268805005339",
            "firstpage": "556",
            "issn": "09502688",
            "lastpage": "566",
            "pmid": "16238823",
            "pub_year": 2006,
            "title": "The natural history of meningococcal carriage and disease",
            "volume": "134"
        },
        "bib0240": {
            "authors": [
                {
                    "first": "Dominique A.",
                    "initial": "D.A.",
                    "last": "Caugant"
                },
                {
                    "first": "Georgina",
                    "initial": "G.",
                    "last": "Tzanakaki"
                },
                {
                    "first": "Paula",
                    "initial": "P.",
                    "last": "Kriz"
                }
            ],
            "doi": "10.1111/j.1574-6976.2006.00052.x",
            "firstpage": "52",
            "issn": "01686445",
            "lastpage": "63",
            "pmid": "17233635",
            "pub_year": 2007,
            "title": "Lessons from meningococcal carriage studies",
            "volume": "31"
        },
        "bib0245": {
            "authors": [
                {
                    "first": "Heike",
                    "initial": "H.",
                    "last": "Claus"
                },
                {
                    "first": "Martin C.J.",
                    "initial": "M.C.J.",
                    "last": "Maiden"
                },
                {
                    "first": "Daniel J.",
                    "initial": "D.J.",
                    "last": "Wilson"
                },
                {
                    "first": "Noel D.",
                    "initial": "N.D.",
                    "last": "McCarthy"
                },
                {
                    "first": "Keith A.",
                    "initial": "K.A.",
                    "last": "Jolley"
                },
                {
                    "first": "Rachel",
                    "initial": "R.",
                    "last": "Urwin"
                },
                {
                    "first": "Frank",
                    "initial": "F.",
                    "last": "Hessler"
                },
                {
                    "first": "Matthias",
                    "initial": "M.",
                    "last": "Frosch"
                },
                {
                    "first": "Ulrich",
                    "initial": "U.",
                    "last": "Vogel"
                }
            ],
            "doi": "10.1086/428590",
            "firstpage": "1263",
            "issn": "00221899",
            "lastpage": "1271",
            "pmid": "15776372",
            "pub_year": 2005,
            "title": "Genetic analysis of meningococci carried by children and young adults",
            "volume": "191"
        },
        "bib0250": {
            "authors": [
                {
                    "first": "Julie A.",
                    "initial": "J.A.",
                    "last": "Bettinger"
                },
                {
                    "first": "David W.",
                    "initial": "D.W.",
                    "last": "Scheifele"
                },
                {
                    "first": "Nicole",
                    "initial": "N.",
                    "last": "Le Saux"
                },
                {
                    "first": "Scott A.",
                    "initial": "S.A.",
                    "last": "Halperin"
                },
                {
                    "first": "Wendy",
                    "initial": "W.",
                    "last": "Vaudry"
                },
                {
                    "first": "Raymond",
                    "initial": "R.",
                    "last": "Tsang"
                }
            ],
            "doi": "10.1097/INF.0b013e3182706b89",
            "firstpage": "e20",
            "issn": "08913668",
            "lastpage": "e25",
            "pmid": "22926207",
            "pub_year": 2013,
            "title": "The disease burden of invasive meningococcal serogroup B disease in Canada",
            "volume": "32"
        },
        "bib0255": {
            "authors": [
                {
                    "first": "Lonny",
                    "initial": "L.",
                    "last": "Erickson"
                },
                {
                    "first": "Philippe",
                    "initial": "P.",
                    "last": "De Wals"
                }
            ],
            "doi": "10.1086/520303",
            "firstpage": "1159",
            "issn": "10584838",
            "lastpage": "1164",
            "pmid": "9597245",
            "pub_year": 1998,
            "title": "Complications and sequelae of meningococcal disease in Quebec, Canada, 1990-1994",
            "volume": "26"
        },
        "bib0260": {
            "authors": [
                {
                    "first": "Magnus",
                    "initial": "M.",
                    "last": "Gottfredsson"
                },
                {
                    "first": "Ingi K.",
                    "initial": "I.K.",
                    "last": "Reynisson"
                },
                {
                    "first": "Ragnar F.",
                    "initial": "R.F.",
                    "last": "Ingvarsson"
                },
                {
                    "first": "Hafrun",
                    "initial": "H.",
                    "last": "Kristjansdottir"
                },
                {
                    "first": "Martina V.",
                    "initial": "M.V.",
                    "last": "Nardini"
                },
                {
                    "first": "Jon F.",
                    "initial": "J.F.",
                    "last": "Sigurdsson"
                },
                {
                    "first": "Rachel",
                    "initial": "R.",
                    "last": "Schneerson"
                },
                {
                    "first": "John B.",
                    "initial": "J.B.",
                    "last": "Robbins"
                },
                {
                    "first": "Mark A.",
                    "initial": "M.A.",
                    "last": "Miller"
                }
            ],
            "doi": "10.1093/cid/cir500",
            "firstpage": "e117",
            "issn": "10584838",
            "lastpage": "e124",
            "pmid": "21946191",
            "pub_year": 2011,
            "title": "Comparative long-term adverse effects elicited by invasive group B and C meningococcal infections",
            "volume": "53"
        },
        "bib0265": {
            "authors": [
                {
                    "first": "C. Mary",
                    "initial": "C.M.",
                    "last": "Healy"
                },
                {
                    "first": "Karina M.",
                    "initial": "K.M.",
                    "last": "Butler"
                },
                {
                    "first": "E. O\u2019brian",
                    "initial": "E.O.",
                    "last": "Smith"
                },
                {
                    "first": "Owen P.",
                    "initial": "O.P.",
                    "last": "Hensey"
                },
                {
                    "first": "Terence",
                    "initial": "T.",
                    "last": "Bate"
                },
                {
                    "first": "Anne C.",
                    "initial": "A.C.",
                    "last": "Moloney"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "MacMahon"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Cosgrove"
                },
                {
                    "first": "Mary T.",
                    "initial": "M.T.",
                    "last": "Cafferkey"
                }
            ],
            "doi": "10.1086/340050",
            "firstpage": "1323",
            "issn": "10584838",
            "lastpage": "1330",
            "pmid": "11981727",
            "pub_year": 2002,
            "title": "Influence of serogroup on the presentation, course, and outcome of invasive meningococcal disease in children in the Republic of Ireland, 1995-2000",
            "volume": "34"
        },
        "bib0270": {
            "authors": [
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Howitz"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Lambertsen"
                },
                {
                    "first": "J. B.",
                    "initial": "J.B.",
                    "last": "Simonsen"
                },
                {
                    "first": "J. J.",
                    "initial": "J.J.",
                    "last": "Christensen"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "M\u00f8lbak"
                }
            ],
            "doi": "10.1017/S0950268809002428",
            "firstpage": "1631",
            "issn": "09502688",
            "lastpage": "1640",
            "pmid": "19327198",
            "pub_year": 2009,
            "title": "Morbidity, mortality and spatial distribution of meningococcal disease, 1974-2007",
            "volume": "137"
        },
        "bib0275": {
            "authors": [
                {
                    "first": "Hareth",
                    "initial": "H.",
                    "last": "Al-Janabi"
                },
                {
                    "first": "Job",
                    "initial": "J.",
                    "last": "Van Exel"
                },
                {
                    "first": "Werner",
                    "initial": "W.",
                    "last": "Brouwer"
                },
                {
                    "first": "Caroline",
                    "initial": "C.",
                    "last": "Trotter"
                },
                {
                    "first": "Linda",
                    "initial": "L.",
                    "last": "Glennie"
                },
                {
                    "first": "Laurie",
                    "initial": "L.",
                    "last": "Hannigan"
                },
                {
                    "first": "Joanna",
                    "initial": "J.",
                    "last": "Coast"
                }
            ],
            "doi": "10.1002/hec.3259",
            "firstpage": "1529",
            "issn": "10579230",
            "lastpage": "1544",
            "pmid": "26464311",
            "pub_year": 2016,
            "title": "Measuring Health Spillovers for Economic Evaluation: A Case Study in Meningitis",
            "volume": "25"
        },
        "bib0280": null,
        "bib0285": null,
        "bib0290": null,
        "bib0295": {
            "authors": [
                {
                    "first": "Vica",
                    "initial": "V.",
                    "last": "Dang"
                },
                {
                    "first": "Frances B.",
                    "initial": "F.B.",
                    "last": "Jamieson"
                },
                {
                    "first": "Sarah",
                    "initial": "S.",
                    "last": "Wilson"
                },
                {
                    "first": "Prasad",
                    "initial": "P.",
                    "last": "Rawte"
                },
                {
                    "first": "Natasha S.",
                    "initial": "N.S.",
                    "last": "Crowcroft"
                },
                {
                    "first": "Karen",
                    "initial": "K.",
                    "last": "Johnson"
                },
                {
                    "first": "Raymond S.W.",
                    "initial": "R.S.W.",
                    "last": "Tsang"
                },
                {
                    "first": "Shelley L.",
                    "initial": "S.L.",
                    "last": "Deeks"
                }
            ],
            "doi": "10.1186/1471-2334-12-202",
            "issn": "14712334",
            "pmid": "22928839",
            "pub_year": 2012,
            "title": "Epidemiology of serogroup B invasive meningococcal disease in Ontario, Canada, 2000 to 2010",
            "volume": "12"
        },
        "bib0300": {
            "authors": [
                {
                    "first": "Elizabeth N.",
                    "initial": "E.N.",
                    "last": "Lewis"
                },
                {
                    "first": "Marie R.",
                    "initial": "M.R.",
                    "last": "Griffin"
                },
                {
                    "first": "Peter G.",
                    "initial": "P.G.",
                    "last": "Szilagyi"
                },
                {
                    "first": "Yuwei",
                    "initial": "Y.",
                    "last": "Zhu"
                },
                {
                    "first": "Kathryn M.",
                    "initial": "K.M.",
                    "last": "Edwards"
                },
                {
                    "first": "Katherine A.",
                    "initial": "K.A.",
                    "last": "Poehling"
                }
            ],
            "doi": "10.1542/peds.2007-0167",
            "firstpage": "467",
            "issn": "00314005",
            "lastpage": "472",
            "pmid": "17766517",
            "pub_year": 2007,
            "title": "Childhood influenza: Number needed to vaccinate to prevent 1 hospitalization or outpatient visit",
            "volume": "120"
        },
        "bib0305": null,
        "bib0310": {
            "authors": [
                {
                    "first": "Robert C.",
                    "initial": "R.C.",
                    "last": "Read"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Baxter"
                },
                {
                    "first": "David R.",
                    "initial": "D.R.",
                    "last": "Chadwick"
                },
                {
                    "first": "Saul N.",
                    "initial": "S.N.",
                    "last": "Faust"
                },
                {
                    "first": "Adam",
                    "initial": "A.",
                    "last": "Finn"
                },
                {
                    "first": "Stephen B.",
                    "initial": "S.B.",
                    "last": "Gordon"
                },
                {
                    "first": "Paul T.",
                    "initial": "P.T.",
                    "last": "Heath"
                },
                {
                    "first": "David J.M.",
                    "initial": "D.J.M.",
                    "last": "Lewis"
                },
                {
                    "first": "Andrew J.",
                    "initial": "A.J.",
                    "last": "Pollard"
                },
                {
                    "first": "David P.J.",
                    "initial": "D.P.J.",
                    "last": "Turner"
                },
                {
                    "first": "Rohit",
                    "initial": "R.",
                    "last": "Bazaz"
                },
                {
                    "first": "Amitava",
                    "initial": "A.",
                    "last": "Ganguli"
                },
                {
                    "first": "Tom",
                    "initial": "T.",
                    "last": "Havelock"
                },
                {
                    "first": "Keith R.",
                    "initial": "K.R.",
                    "last": "Neal"
                },
                {
                    "first": "Ifeanyichukwu O.",
                    "initial": "I.O.",
                    "last": "Okike"
                },
                {
                    "first": "Begonia",
                    "initial": "B.",
                    "last": "Morales-Aza"
                },
                {
                    "first": "Kamlesh",
                    "initial": "K.",
                    "last": "Patel"
                },
                {
                    "first": "Matthew D.",
                    "initial": "M.D.",
                    "last": "Snape"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Williams"
                },
                {
                    "first": "Stefanie",
                    "initial": "S.",
                    "last": "Gilchrist"
                },
                {
                    "first": "Steve J.",
                    "initial": "S.J.",
                    "last": "Gray"
                },
                {
                    "first": "Martin C.J.",
                    "initial": "M.C.J.",
                    "last": "Maiden"
                },
                {
                    "first": "Daniela",
                    "initial": "D.",
                    "last": "Toneatto"
                },
                {
                    "first": "Huajun",
                    "initial": "H.",
                    "last": "Wang"
                },
                {
                    "first": "Maggie",
                    "initial": "M.",
                    "last": "McCarthy"
                },
                {
                    "first": "Peter M.",
                    "initial": "P.M.",
                    "last": "Dull"
                },
                {
                    "first": "Ray",
                    "initial": "R.",
                    "last": "Borrow"
                }
            ],
            "doi": "10.1016/S0140-6736(14)60842-4",
            "firstpage": "2123",
            "issn": "01406736",
            "lastpage": "2131",
            "pmid": "25145775",
            "pub_year": 2014,
            "title": "Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: An observer-blind, phase 3 randomised clinical trial",
            "volume": "384"
        },
        "bib0315": {
            "authors": [
                {
                    "first": "Lucy A.",
                    "initial": "L.A.",
                    "last": "McNamara"
                },
                {
                    "first": "Alice M.",
                    "initial": "A.M.",
                    "last": "Shumate"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Johnsen"
                },
                {
                    "first": "Jessica R.",
                    "initial": "J.R.",
                    "last": "MacNeil"
                },
                {
                    "first": "Manisha",
                    "initial": "M.",
                    "last": "Patel"
                },
                {
                    "first": "Tina",
                    "initial": "T.",
                    "last": "Bhavsar"
                },
                {
                    "first": "Amanda C.",
                    "initial": "A.C.",
                    "last": "Cohn"
                },
                {
                    "first": "Jill",
                    "initial": "J.",
                    "last": "Dinitz-Sklar"
                },
                {
                    "first": "Jonathan",
                    "initial": "J.",
                    "last": "Duffy"
                },
                {
                    "first": "Janet",
                    "initial": "J.",
                    "last": "Finnie"
                },
                {
                    "first": "Denise",
                    "initial": "D.",
                    "last": "Garon"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Hary"
                },
                {
                    "first": "Fang",
                    "initial": "F.",
                    "last": "Hu"
                },
                {
                    "first": "Hajime",
                    "initial": "H.",
                    "last": "Kamiya"
                },
                {
                    "first": "Hye Joo",
                    "initial": "H.J.",
                    "last": "Kim"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Kolligian"
                },
                {
                    "first": "Janet",
                    "initial": "J.",
                    "last": "Neglia"
                },
                {
                    "first": "Judith",
                    "initial": "J.",
                    "last": "Oakley"
                },
                {
                    "first": "Jacqueline",
                    "initial": "J.",
                    "last": "Wagner"
                },
                {
                    "first": "Kathy",
                    "initial": "K.",
                    "last": "Wagner"
                },
                {
                    "first": "Xin",
                    "initial": "X.",
                    "last": "Wang"
                },
                {
                    "first": "Yon",
                    "initial": "Y.",
                    "last": "Yu"
                },
                {
                    "first": "Barbara",
                    "initial": "B.",
                    "last": "Montana"
                },
                {
                    "first": "Christina",
                    "initial": "C.",
                    "last": "Tan"
                },
                {
                    "first": "Robin",
                    "initial": "R.",
                    "last": "Izzo"
                },
                {
                    "first": "Thomas A.",
                    "initial": "T.A.",
                    "last": "Clark"
                }
            ],
            "doi": "10.1542/peds.2014-4015",
            "firstpage": "798",
            "issn": "00314005",
            "lastpage": "804",
            "pmid": "25917990",
            "pub_year": 2015,
            "title": "First use of a serogroup B meningococcal vaccine in the US in response to a university outbreak",
            "volume": "135"
        },
        "bib0320": {
            "authors": [
                {
                    "first": "Thorsten",
                    "initial": "T.",
                    "last": "Rieck"
                },
                {
                    "first": "Marcel",
                    "initial": "M.",
                    "last": "Feig"
                },
                {
                    "first": "Tim",
                    "initial": "T.",
                    "last": "Eckmanns"
                },
                {
                    "first": "Justus",
                    "initial": "J.",
                    "last": "Benzler"
                },
                {
                    "first": "Anette",
                    "initial": "A.",
                    "last": "Siedler"
                },
                {
                    "first": "Ole",
                    "initial": "O.",
                    "last": "Wichmann"
                }
            ],
            "doi": "10.4161/hv.26986",
            "firstpage": "476",
            "issn": "21645515",
            "lastpage": "484",
            "pmid": "24192604",
            "pub_year": 2014,
            "title": "Vaccination coverage among children in Germany estimated by analysis of health insurance claims data",
            "volume": "10"
        },
        "bib0325": {
            "authors": [
                {
                    "first": "Hannah",
                    "initial": "H.",
                    "last": "Christensen"
                },
                {
                    "first": "Caroline L.",
                    "initial": "C.L.",
                    "last": "Trotter"
                },
                {
                    "first": "Matthew",
                    "initial": "M.",
                    "last": "Hickman"
                },
                {
                    "first": "W. John",
                    "initial": "W.J.",
                    "last": "Edmunds"
                }
            ],
            "doi": "10.1136/bmj.g5725",
            "issn": "09598146",
            "pmid": "25301037",
            "pub_year": 2014,
            "title": "Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: Modelling study",
            "volume": "349"
        },
        "bib0330": {
            "authors": [
                {
                    "first": "Hong Anh T.",
                    "initial": "H.A.T.",
                    "last": "Tu"
                },
                {
                    "first": "Shelley L.",
                    "initial": "S.L.",
                    "last": "Deeks"
                },
                {
                    "first": "Shaun K.",
                    "initial": "S.K.",
                    "last": "Morris"
                },
                {
                    "first": "Lisa",
                    "initial": "L.",
                    "last": "Strifler"
                },
                {
                    "first": "Natasha",
                    "initial": "N.",
                    "last": "Crowcroft"
                },
                {
                    "first": "Frances B.",
                    "initial": "F.B.",
                    "last": "Jamieson"
                },
                {
                    "first": "Jeffrey C.",
                    "initial": "J.C.",
                    "last": "Kwong"
                },
                {
                    "first": "Peter C.",
                    "initial": "P.C.",
                    "last": "Coyte"
                },
                {
                    "first": "Murray",
                    "initial": "M.",
                    "last": "Krahn"
                },
                {
                    "first": "Beate",
                    "initial": "B.",
                    "last": "Sander"
                }
            ],
            "doi": "10.1016/j.vaccine.2014.07.096",
            "firstpage": "5436",
            "issn": "0264410X",
            "lastpage": "5446",
            "pmid": "25131732",
            "pub_year": 2014,
            "title": "Economic evaluation of meningococcal serogroup B childhood vaccination in Ontario, Canada",
            "volume": "32"
        },
        "bib0335": {
            "authors": [
                {
                    "first": "Koen B.",
                    "initial": "K.B.",
                    "last": "Pouwels"
                },
                {
                    "first": "Eelko",
                    "initial": "E.",
                    "last": "Hak"
                },
                {
                    "first": "Arie",
                    "initial": "A.",
                    "last": "Van Der Ende"
                },
                {
                    "first": "Hannah",
                    "initial": "H.",
                    "last": "Christensen"
                },
                {
                    "first": "Germie P.J.M.",
                    "initial": "G.P.J.M.",
                    "last": "Van Den Dobbelsteen"
                },
                {
                    "first": "Maarten J.",
                    "initial": "M.J.",
                    "last": "Postma"
                }
            ],
            "doi": "10.4161/hv.23888",
            "firstpage": "1129",
            "issn": "21645515",
            "lastpage": "1138",
            "pmid": "23406816",
            "pub_year": 2013,
            "title": "Cost-effectiveness of vaccination against meningococcal B among Dutch infants: Crucial impact of changes in incidence",
            "volume": "9"
        },
        "bib0340": null,
        "bib0345": null,
        "bib0350": {
            "authors": [
                {
                    "first": "Fiona",
                    "initial": "F.",
                    "last": "McQuaid"
                },
                {
                    "first": "Matthew D.",
                    "initial": "M.D.",
                    "last": "Snape"
                },
                {
                    "first": "Tessa M.",
                    "initial": "T.M.",
                    "last": "John"
                },
                {
                    "first": "Sarah",
                    "initial": "S.",
                    "last": "Kelly"
                },
                {
                    "first": "Hannah",
                    "initial": "H.",
                    "last": "Robinson"
                },
                {
                    "first": "Jennifer",
                    "initial": "J.",
                    "last": "Houlden"
                },
                {
                    "first": "Merryn",
                    "initial": "M.",
                    "last": "Voysey"
                },
                {
                    "first": "Daniela",
                    "initial": "D.",
                    "last": "Toneatto"
                },
                {
                    "first": "Claudia",
                    "initial": "C.",
                    "last": "Kitte"
                },
                {
                    "first": "Peter M.",
                    "initial": "P.M.",
                    "last": "Dull"
                },
                {
                    "first": "Andrew J.",
                    "initial": "A.J.",
                    "last": "Pollard"
                }
            ],
            "doi": "10.1097/INF.0000000000000327",
            "firstpage": "760",
            "issn": "08913668",
            "lastpage": "766",
            "pmid": "24722351",
            "pub_year": 2014,
            "title": "Persistence of bactericidal antibodies to 5 years of age after immunization with serogroup B meningococcal vaccines at 6, 8, 12 and 40 months of age",
            "volume": "33"
        },
        "bib0355": {
            "authors": [
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Huels"
                },
                {
                    "first": "K. M.",
                    "initial": "K.M.",
                    "last": "Clements"
                },
                {
                    "first": "L. J.",
                    "initial": "L.J.",
                    "last": "McGarry"
                },
                {
                    "first": "G. J.",
                    "initial": "G.J.",
                    "last": "Hill"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Wassil"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Kessabi"
                }
            ],
            "doi": "10.1017/S095026881300294X",
            "firstpage": "2000",
            "issn": "09502688",
            "lastpage": "2012",
            "pmid": "24284038",
            "pub_year": 2014,
            "title": "Modelled evaluation of multi-component meningococcal vaccine (Bexsero \u00ae) for the prevention of invasive meningococcal disease in infants and adolescents in the UK",
            "volume": "142"
        },
        "bib0360": null,
        "bib0365": null,
        "bib0370": {
            "authors": [
                {
                    "first": "Anja",
                    "initial": "A.",
                    "last": "Takla"
                },
                {
                    "first": "Ole",
                    "initial": "O.",
                    "last": "Wichmann"
                },
                {
                    "first": "Judith",
                    "initial": "J.",
                    "last": "Koch"
                },
                {
                    "first": "Martin",
                    "initial": "M.",
                    "last": "Terhardt"
                },
                {
                    "first": "Wiebke",
                    "initial": "W.",
                    "last": "Hellenbrand"
                }
            ],
            "doi": "10.1016/j.vaccine.2014.09.040",
            "firstpage": "6349",
            "issn": "0264410X",
            "lastpage": "6355",
            "pmid": "25280437",
            "pub_year": 2014,
            "title": "Survey of pediatricians in Germany reveals important challenges for possible implementation of meningococcal B vaccination",
            "volume": "32"
        }
    },
    "body_text": [
        {
            "endOffset": 32261,
            "parents": [],
            "secId": "sec0080",
            "sentence": "From the societal perspective ICERs were lower, but remained over one million Euros per QALY gained even when allowing for herd effects (Appendix).",
            "startOffset": 32114,
            "title": "Sensitivity analyses"
        },
        {
            "endOffset": 35224,
            "parents": [],
            "secId": "sec0080",
            "sentence": "Of the parameters considered probabilistically in the cohort model, the incremental costs of vaccination were most sensitive to the vaccine administration costs and the rates of adverse vaccine reactions; incremental QALYs gained were most sensitive to the quality of life loss utilities and to a lesser extent the proportion of people with sequelae associated with disease and long-term sequelae (Appendix).",
            "startOffset": 34816,
            "title": "Sensitivity analyses"
        },
        {
            "endOffset": 28544,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                },
                {
                    "id": "sec0055",
                    "title": "Health impact"
                }
            ],
            "secId": "sec0060",
            "sentence": "Adding a large one-off catch-up strategy for 1\u201317 year olds to the routine infant schedule averted more cases.",
            "startOffset": 28434,
            "title": "Cohort model: direct effects (no vaccine effects on carriage)"
        },
        {
            "endOffset": 20814,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "secId": "sec0015",
            "sentence": "Vaccine induced protection was assumed to start one month after the second vaccine dose and we allowed for waning protection (modelled as a constant rate set to the reciprocal of the average duration of vaccine protection).",
            "startOffset": 20591,
            "title": "Models"
        },
        {
            "endOffset": 38666,
            "parents": [
                {
                    "id": "sec0085",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "bib0350": {
                    "endOffset": 38665,
                    "startOffset": 38661
                }
            },
            "secId": "sec0095",
            "sentence": "In addition, duration of protection in scenarios that included catch-up vaccination of toddlers may be overoptimistic based on a recently published small study of hSBA persistence [33].",
            "startOffset": 38481,
            "title": "Strengths and limitations"
        },
        {
            "endOffset": 33341,
            "parents": [],
            "secId": "sec0080",
            "sentence": "Increasing vaccine uptake in infants from 65% to 70% resulted in an estimated 1% point increase in cases averted assuming direct protection only or 2% point increase when including herd effects.",
            "startOffset": 33147,
            "title": "Sensitivity analyses"
        },
        {
            "endOffset": 28845,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                },
                {
                    "id": "sec0055",
                    "title": "Health impact"
                }
            ],
            "secId": "sec0065",
            "sentence": "We assumed a 30% vaccine efficacy against acquisition.",
            "startOffset": 28791,
            "title": "Dynamic transmission model: incorporating herd effects following vaccination"
        },
        {
            "endOffset": 40102,
            "parents": [
                {
                    "id": "sec0085",
                    "title": "Discussion"
                }
            ],
            "secId": "sec0100",
            "sentence": "This is in part explained by a higher vaccine price, the lower sequelae costs assigned to MenB patients as well as the very low MenB incidence (lower only in the Canadian model that also estimated high ICERs > $CDN 3 Million for infant vaccination).",
            "startOffset": 39853,
            "title": "Comparison with other studies"
        },
        {
            "endOffset": 38285,
            "parents": [
                {
                    "id": "sec0085",
                    "title": "Discussion"
                }
            ],
            "secId": "sec0095",
            "sentence": "In other aspects the model parameters were potentially vaccine favourable.",
            "startOffset": 38211,
            "title": "Strengths and limitations"
        },
        {
            "endOffset": 22872,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                },
                {
                    "id": "sec0015",
                    "title": "Models"
                }
            ],
            "secId": "sec0025",
            "sentence": "Disease cases were generated by applying an age-specific case:carrier ratio to the number of new carriage acquisitions.",
            "startOffset": 22753,
            "title": "Dynamic model specific details"
        },
        {
            "endOffset": 22562,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                },
                {
                    "id": "sec0015",
                    "title": "Models"
                }
            ],
            "secId": "sec0025",
            "sentence": "Vaccinated individuals with immunity could have protection against carriage acquisition (initially assumed to be 30% reduction in carriage acquisition) as well as disease.",
            "startOffset": 22391,
            "title": "Dynamic model specific details"
        },
        {
            "endOffset": 20006,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "secId": "sec0015",
            "sentence": "Due to existent universal MenC vaccination in Germany and an extremely low incidence of meningococcal disease due to non-B serogroups (0.15 cases per 100,000 from 2009 to 2012), we considered MenB disease exclusively in the models.",
            "startOffset": 19775,
            "title": "Models"
        },
        {
            "endOffset": 31693,
            "parents": [],
            "secId": "sec0080",
            "sentence": "Allowing for lower vaccine strain coverage in infants compared to older age groups (<1 year 68%; 1\u20139 years 88%; 10\u201319 years 86%; 20\u201349 years 79%; 50+ years 76%, see Appendix) reduced the estimated cases directly averted from 34 to 32 over the cohort's lifetime.",
            "startOffset": 31432,
            "title": "Sensitivity analyses"
        },
        {
            "endOffset": 23949,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "bib0190": {
                    "endOffset": 23948,
                    "startOffset": 23939
                },
                "bib0250": {
                    "endOffset": 23948,
                    "startOffset": 23939
                },
                "bib0255": {
                    "endOffset": 23948,
                    "startOffset": 23939
                },
                "bib0260": {
                    "endOffset": 23948,
                    "startOffset": 23939
                },
                "bib0265": {
                    "endOffset": 23948,
                    "startOffset": 23939
                },
                "bib0270": {
                    "endOffset": 23948,
                    "startOffset": 23939
                }
            },
            "secId": "sec0030",
            "sentence": "The proportion of survivors with mild and severe sequelae was estimated from the literature [13\u201317,1].",
            "startOffset": 23847,
            "title": "Model parameters"
        },
        {
            "endOffset": 36653,
            "parents": [
                {
                    "id": "sec0085",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "bib0310": {
                    "endOffset": 36652,
                    "startOffset": 36645
                },
                "bib0315": {
                    "endOffset": 36652,
                    "startOffset": 36645
                }
            },
            "secId": "sec0090",
            "sentence": "This was driven by the low absolute number of preventable cases predicted, particularly by the models that assumed no herd effects, however, evidence for an impact on carriage is uncertain [25,26].",
            "startOffset": 36456,
            "title": "Principal findings"
        },
        {
            "endOffset": 17236,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Over this period MenB accounted for 68.5% of IMD cases; 22% were due to MenC, 5.2% due to MenY, 3.4% due to MenW and the remainder due to groups A, Z and 29E.",
            "startOffset": 17078,
            "title": "Introduction"
        },
        {
            "endOffset": 40483,
            "parents": [
                {
                    "id": "sec0085",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "bib0370": {
                    "endOffset": 40482,
                    "startOffset": 40478
                }
            },
            "secId": "sec0105",
            "sentence": "However, a recent study of paediatricians in Germany suggested only 13.4% of physicians preferred this strategy, in contrast to the 66.7% who preferred vaccination at 6, 8, 12 months (14% chose neither schedule) [37].",
            "startOffset": 40266,
            "title": "Implications for policy makers"
        },
        {
            "endOffset": 35767,
            "parents": [
                {
                    "id": "sec0085",
                    "title": "Discussion"
                }
            ],
            "secId": "sec0090",
            "sentence": "Delaying the age at which the vaccine course is started reduces the potential health impact because young infants are at greatest risk of disease.",
            "startOffset": 35621,
            "title": "Principal findings"
        },
        {
            "endOffset": 26742,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "secId": "sec0045",
            "sentence": "Parameter uncertainty was handled through scenario analyses and by probabilistic sensitivity analyses (PSA).",
            "startOffset": 26634,
            "title": "Scenario analyses"
        },
        {
            "endOffset": 18428,
            "parents": [],
            "refoffsets": {
                "bib0215": {
                    "endOffset": 18427,
                    "startOffset": 18424
                }
            },
            "secId": "sec0005",
            "sentence": "This vaccine is based upon a number of surface proteins and an outer membrane vesicle component, and is thus potentially immunogenic against strains with sufficient expression of the vaccine antigens regardless of the capsular group [6].",
            "startOffset": 18191,
            "title": "Introduction"
        },
        {
            "endOffset": 27937,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                },
                {
                    "id": "sec0055",
                    "title": "Health impact"
                }
            ],
            "secId": "sec0060",
            "sentence": "In the absence of MenB vaccination the model estimates 224 cases of MenB disease and 19 deaths would occur over a cohort's lifetime.",
            "startOffset": 27805,
            "title": "Cohort model: direct effects (no vaccine effects on carriage)"
        },
        {
            "endOffset": 21080,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                },
                {
                    "id": "sec0015",
                    "title": "Models"
                }
            ],
            "secId": "sec0020",
            "sentence": "A Markov model with monthly cycles was used (Appendix).",
            "startOffset": 21025,
            "title": "Cohort model specific details"
        },
        {
            "endOffset": 40724,
            "parents": [
                {
                    "id": "sec0085",
                    "title": "Discussion"
                }
            ],
            "secId": "sec0105",
            "sentence": "Paediatricians were concerned about acceptance and safety of concomitant vaccination and possible parental refusal of other recommended vaccines since vaccinating MenB early in life would usually involve three vaccine shots per appointment.",
            "startOffset": 40484,
            "title": "Implications for policy makers"
        },
        {
            "endOffset": 25684,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "Costs of vaccine administration were estimated from administration costs for other vaccines in Germany.",
            "startOffset": 25581,
            "title": "Model parameters"
        },
        {
            "endOffset": 32011,
            "parents": [],
            "secId": "sec0080",
            "sentence": "Both models were also sensitive to disease incidence (Appendix).",
            "startOffset": 31947,
            "title": "Sensitivity analyses"
        },
        {
            "endOffset": 34190,
            "parents": [],
            "secId": "sec0080",
            "sentence": "ICERs remained very high even when using vaccine favourable assumptions or allowing for herd effects.",
            "startOffset": 34089,
            "title": "Sensitivity analyses"
        },
        {
            "endOffset": 41659,
            "parents": [],
            "secId": "sec0110",
            "sentence": "Funding: This work was supported by the Robert Koch Institute.",
            "startOffset": 41597,
            "title": "Conclusions"
        },
        {
            "endOffset": 39094,
            "parents": [
                {
                    "id": "sec0085",
                    "title": "Discussion"
                }
            ],
            "secId": "sec0100",
            "sentence": "As for the German models presented here, the England and Belgian analyses included the use of dynamic transmission models to appropriately allow for any herd effects.",
            "startOffset": 38928,
            "title": "Comparison with other studies"
        },
        {
            "endOffset": 17622,
            "parents": [],
            "refoffsets": {
                "bib0195": {
                    "endOffset": 17621,
                    "startOffset": 17618
                }
            },
            "secId": "sec0005",
            "sentence": "As in other European countries, annual IMD incidence has decreased markedly in Germany, with MenB IMD decreasing from a mean of 0.49 to 0.30 cases/100,000 inhabitants from 2002\u20132005 to 2009\u20132012, and MenC IMD from 0.18 to 0.11 cases/100,000 inhabitants [2].",
            "startOffset": 17365,
            "title": "Introduction"
        },
        {
            "endOffset": 35865,
            "parents": [
                {
                    "id": "sec0085",
                    "title": "Discussion"
                }
            ],
            "secId": "sec0090",
            "sentence": "The limited impact of MenB vaccination in the German setting is also reflected in very high NNVs.",
            "startOffset": 35768,
            "title": "Principal findings"
        },
        {
            "endOffset": 25580,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "The 2015 pharmacy retail price of \u20ac96.96 was used as the cost per vaccine dose.",
            "startOffset": 25501,
            "title": "Model parameters"
        },
        {
            "endOffset": 35620,
            "parents": [
                {
                    "id": "sec0085",
                    "title": "Discussion"
                }
            ],
            "secId": "sec0090",
            "sentence": "This low absolute impact is due to the very low MenB incidence and only moderate anticipated vaccination uptake in Germany.",
            "startOffset": 35497,
            "title": "Principal findings"
        },
        {
            "endOffset": 39680,
            "parents": [
                {
                    "id": "sec0085",
                    "title": "Discussion"
                }
            ],
            "secId": "sec0100",
            "sentence": "The predictions here for vaccination in Germany are in line with those estimated elsewhere, namely that in the absence of herd effects routine immunisation early in life offers the greatest health impact, but with the inclusion of herd effects routine immunisation of teenagers becomes the best long-term strategy.",
            "startOffset": 39366,
            "title": "Comparison with other studies"
        },
        {
            "endOffset": 23565,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "National surveillance data from RKI were used to estimate age-specific disease incidence (data from 2009 to 2012) and case fatality (2002 to 2012) for MenB disease; the longer time period was used for case fatality due to the small annual number of meningococcal deaths.",
            "startOffset": 23295,
            "title": "Model parameters"
        },
        {
            "endOffset": 21323,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                },
                {
                    "id": "sec0015",
                    "title": "Models"
                }
            ],
            "secId": "sec0020",
            "sentence": "Years of life were weighted by the age-specific quality of life.",
            "startOffset": 21259,
            "title": "Cohort model specific details"
        },
        {
            "endOffset": 31431,
            "parents": [],
            "secId": "sec0080",
            "sentence": "Increasing the strain coverage to 92% resulted in a 2% point increase in averted cases assuming direct protection only or 3% point increase allowing for herd effects.",
            "startOffset": 31265,
            "title": "Sensitivity analyses"
        },
        {
            "endOffset": 28433,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                },
                {
                    "id": "sec0055",
                    "title": "Health impact"
                }
            ],
            "secId": "sec0060",
            "sentence": "To consider catch-up strategies additional birth cohorts are included.",
            "startOffset": 28363,
            "title": "Cohort model: direct effects (no vaccine effects on carriage)"
        },
        {
            "endOffset": 21258,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                },
                {
                    "id": "sec0015",
                    "title": "Models"
                }
            ],
            "secId": "sec0020",
            "sentence": "Disease cases were generated through applying the age-specific probability of disease to the susceptible population; survivors of disease were removed from the susceptible pool.",
            "startOffset": 21081,
            "title": "Cohort model specific details"
        },
        {
            "endOffset": 28710,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                },
                {
                    "id": "sec0055",
                    "title": "Health impact"
                }
            ],
            "secId": "sec0060",
            "sentence": "However, the percentage averted is reduced (from 15% to 6%) because incidence and assumed vaccine uptake are lower in 1\u201317 year olds compared to under one-year olds.",
            "startOffset": 28545,
            "title": "Cohort model: direct effects (no vaccine effects on carriage)"
        },
        {
            "endOffset": 29427,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                },
                {
                    "id": "sec0055",
                    "title": "Health impact"
                }
            ],
            "secId": "sec0065",
            "sentence": "In the long term (20 years or more) policies including routine vaccination of 12 year olds are most favourable; after 50 years routine adolescent vaccination leads to an annual case reduction of 37.9% compared to no vaccination (Fig. 3).",
            "startOffset": 29190,
            "title": "Dynamic transmission model: incorporating herd effects following vaccination"
        },
        {
            "endOffset": 25931,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "We included the costs of hospitalisation for severe fever and anaphylaxis as possible adverse events following vaccination, but did not include possible quality of life losses associated with adverse events, which were assumed to resolve quickly.",
            "startOffset": 25685,
            "title": "Model parameters"
        },
        {
            "endOffset": 23179,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "Details of the data sources used to estimate parameters are summarised below with full details provided in Appendix.",
            "startOffset": 23063,
            "title": "Model parameters"
        },
        {
            "endOffset": 20095,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "secId": "sec0015",
            "sentence": "Both models are age-structured with yearly age classes; individuals are born susceptible.",
            "startOffset": 20006,
            "title": "Models"
        },
        {
            "endOffset": 38210,
            "parents": [
                {
                    "id": "sec0085",
                    "title": "Discussion"
                }
            ],
            "secId": "sec0095",
            "sentence": "Not including the full range and costs of possible sequelae from meningococcal disease will have increased the estimated cost per QALY gained of the vaccination strategies, however in sensitivity analyses ICERs remained high even when the proportion of patients with sequelae and their associated costs were increased.",
            "startOffset": 37892,
            "title": "Strengths and limitations"
        },
        {
            "endOffset": 36270,
            "parents": [
                {
                    "id": "sec0085",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "bib0300": {
                    "endOffset": 36160,
                    "startOffset": 36156
                },
                "bib0305": {
                    "endOffset": 36269,
                    "startOffset": 36265
                }
            },
            "secId": "sec0090",
            "sentence": "For comparison, much lower NNVs have been estimated to prevent one influenza-related hospitalisation when vaccinating children aged 6\u201323 months with an influenza vaccine at 50% efficacy (NNV 1031\u20133050) [23] and an estimated 80 children would need to receive rotavirus vaccination to prevent one hospitalisation [24].",
            "startOffset": 35954,
            "title": "Principal findings"
        },
        {
            "endOffset": 38480,
            "parents": [
                {
                    "id": "sec0085",
                    "title": "Discussion"
                }
            ],
            "secId": "sec0095",
            "sentence": "For instance, we did not include quality of life losses from adverse vaccine reactions, allowances for strain replacement or potential deleterious effects of reducing meningococcal transmission.",
            "startOffset": 38286,
            "title": "Strengths and limitations"
        },
        {
            "endOffset": 41994,
            "parents": [],
            "secId": "sec0110",
            "sentence": "HC is a member of the NIHR Health Protection Research Unit in Evaluation of Interventions at University of Bristol.",
            "startOffset": 41879,
            "title": "Conclusions"
        },
        {
            "endOffset": 17364,
            "parents": [],
            "refoffsets": {
                "bib0190": {
                    "endOffset": 17363,
                    "startOffset": 17360
                }
            },
            "secId": "sec0005",
            "sentence": "While most people recover, the disease can leave survivors with a range of disabling sequelae, from deafness to amputation [1].",
            "startOffset": 17237,
            "title": "Introduction"
        },
        {
            "endOffset": 24636,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "The costs of aftercare included one follow-up appointment for those aged under 5 years, cochlear implants (0.4% of survivors), scarring treatment (4%), physical therapy (1.9%) and logopaedics treatment (3.7% of survivors under 19 years) for the year following illness.",
            "startOffset": 24368,
            "title": "Model parameters"
        },
        {
            "endOffset": 41395,
            "parents": [],
            "secId": "sec0110",
            "sentence": "If the vaccine has an effect on carriage, the prevented number of cases and deaths increase significantly when vaccinating adolescents alone or \u2013 even more \u2013 when adding adolescent vaccination to a routine infant vaccination strategy.",
            "startOffset": 41161,
            "title": "Conclusions"
        },
        {
            "endOffset": 37432,
            "parents": [
                {
                    "id": "sec0085",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "bib0320": {
                    "endOffset": 37431,
                    "startOffset": 37427
                }
            },
            "secId": "sec0095",
            "sentence": "The models here consider MenB disease only, as we considered the impact on other serogroups would be very limited given their low incidence (there were only 42, 6 and 7 cases annually of MenC, W and Y, respectively in under 20 year olds from 2009 to 2012) and MenC vaccination coverage in targeted cohorts is already very high [27].",
            "startOffset": 37100,
            "title": "Strengths and limitations"
        },
        {
            "endOffset": 18829,
            "parents": [],
            "refoffsets": {
                "bib0220": {
                    "endOffset": 18828,
                    "startOffset": 18825
                }
            },
            "secId": "sec0005",
            "sentence": "Currently STIKO recommends Bexsero\u00ae for persons at increased risk of acquiring IMD, but not for universal childhood vaccination [7].",
            "startOffset": 18697,
            "title": "Introduction"
        },
        {
            "endOffset": 39852,
            "parents": [
                {
                    "id": "sec0085",
                    "title": "Discussion"
                }
            ],
            "secId": "sec0100",
            "sentence": "Although the ICERs under base case conditions have been found to be high in all countries considered thus far, those presented for Germany are amongst the highest to date.",
            "startOffset": 39681,
            "title": "Comparison with other studies"
        },
        {
            "endOffset": 33770,
            "parents": [],
            "secId": "sec0080",
            "sentence": "Allowing for lower vaccine strain coverage in infants compared to older age groups (<1 year 68%; 1\u20139 years 88%; 10\u201319 years 86%; 20\u201349 years 79%; 50+ years 76%, see Appendix) reduced the estimated cases directly averted from 34 to 32 over the cohort's lifetime.",
            "startOffset": 33509,
            "title": "Sensitivity analyses"
        },
        {
            "endOffset": 42503,
            "parents": [],
            "secId": "sec0110",
            "sentence": "Remaining authors: no reported conflicts.",
            "startOffset": 42462,
            "title": "Conclusions"
        },
        {
            "endOffset": 21833,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                },
                {
                    "id": "sec0015",
                    "title": "Models"
                }
            ],
            "secId": "sec0020",
            "sentence": "Years of life were weighted by the age-specific quality of life.",
            "startOffset": 21769,
            "title": "Cohort model specific details"
        },
        {
            "endOffset": 20991,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "secId": "sec0015",
            "sentence": "We considered several vaccination strategies (Table 1), comparing these to no universal vaccination against MenB and treating cases as they arise, over a 100 year time horizon.",
            "startOffset": 20815,
            "title": "Models"
        },
        {
            "endOffset": 22045,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                },
                {
                    "id": "sec0015",
                    "title": "Models"
                }
            ],
            "secId": "sec0020",
            "sentence": "Single birth cohorts were considered for routine infant or toddler vaccination; multiple cohorts were considered for strategies with catch-up vaccination.",
            "startOffset": 21891,
            "title": "Cohort model specific details"
        },
        {
            "endOffset": 24189,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "bib0190": {
                    "endOffset": 24117,
                    "startOffset": 24114
                },
                "bib0275": {
                    "endOffset": 24188,
                    "startOffset": 24184
                }
            },
            "secId": "sec0030",
            "sentence": "Quality of life losses for survivors with sequelae were based on currently unpublished data from the MOSAIC study, a case\u2013control study of MenB survivors in the UK [1]; losses for carers of a person with sequelae were also considered [18].",
            "startOffset": 23950,
            "title": "Model parameters"
        },
        {
            "endOffset": 41878,
            "parents": [],
            "secId": "sec0110",
            "sentence": "This work is produced by the authors under the terms of these research training fellowships issued by the NIHR.",
            "startOffset": 41767,
            "title": "Conclusions"
        },
        {
            "endOffset": 36849,
            "parents": [
                {
                    "id": "sec0085",
                    "title": "Discussion"
                }
            ],
            "secId": "sec0095",
            "sentence": "Our models use the latest available German specific data where possible and the use of a transmission dynamic model allows for indirect vaccine benefits (herd effects).",
            "startOffset": 36681,
            "title": "Strengths and limitations"
        },
        {
            "endOffset": 23295,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "Details of the data sources used to estimate parameters are summarised below with full details provided in Appendix.",
            "startOffset": 23179,
            "title": "Model parameters"
        },
        {
            "endOffset": 39365,
            "parents": [
                {
                    "id": "sec0085",
                    "title": "Discussion"
                }
            ],
            "secId": "sec0100",
            "sentence": "In France herd effects were estimated through incorporation into a Markov model and direct protection was principally considered in the Dutch and the Canadian studies primarily due to limited evidence of the effect of Bexsero\u00ae on meningococcal carriage and transmission.",
            "startOffset": 39095,
            "title": "Comparison with other studies"
        },
        {
            "endOffset": 25500,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "bib0215": {
                    "endOffset": 25499,
                    "startOffset": 25493
                },
                "bib0280": {
                    "endOffset": 25499,
                    "startOffset": 25493
                }
            },
            "secId": "sec0030",
            "sentence": "Vaccine strain coverage was estimated using results of the Meningococcal antigen typing system (MATS) assay on German strains [6,19].",
            "startOffset": 25367,
            "title": "Model parameters"
        },
        {
            "endOffset": 40265,
            "parents": [
                {
                    "id": "sec0085",
                    "title": "Discussion"
                }
            ],
            "secId": "sec0105",
            "sentence": "Our models suggest that maximal health impact in the short term could be achieved in Germany by vaccinating infants early in life.",
            "startOffset": 40135,
            "title": "Implications for policy makers"
        },
        {
            "endOffset": 32517,
            "parents": [],
            "secId": "sec0080",
            "sentence": "Reducing the cost of the vaccine considerably reduced the ICER, however the cost per QALY gained remained over \u20ac100,000 even with a vaccine price of \u20ac0 and including herd effects (up to 60% efficacy against carriage acquisition) for the infant strategies.",
            "startOffset": 32262,
            "title": "Sensitivity analyses"
        },
        {
            "endOffset": 32113,
            "parents": [],
            "secId": "sec0080",
            "sentence": "ICERs remained very high even when using vaccine favourable assumptions or allowing for herd effects.",
            "startOffset": 32012,
            "title": "Sensitivity analyses"
        },
        {
            "endOffset": 26292,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "secId": "sec0040",
            "sentence": "Health outcomes were defined as cases averted, deaths averted and quality adjusted life years (QALYs) gained under vaccination.",
            "startOffset": 26165,
            "title": "Cost-effectiveness analyses"
        },
        {
            "endOffset": 29189,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                },
                {
                    "id": "sec0055",
                    "title": "Health impact"
                }
            ],
            "secId": "sec0065",
            "sentence": "The greatest health benefit in the short term, however, is achieved through routine infant vaccination with large-scale catch-up, which could reduce cases by 24.9% after 5 years and 27.9% after 10 years (Fig. 3).",
            "startOffset": 28977,
            "title": "Dynamic transmission model: incorporating herd effects following vaccination"
        },
        {
            "endOffset": 42169,
            "parents": [],
            "secId": "sec0110",
            "sentence": "The views expressed in this publication are those of the authors and not necessarily those of the NHS, The National Institute for Health Research or the Department of Health.",
            "startOffset": 41995,
            "title": "Conclusions"
        },
        {
            "endOffset": 17785,
            "parents": [],
            "refoffsets": {
                "bib0200": {
                    "endOffset": 17784,
                    "startOffset": 17779
                },
                "bib0205": {
                    "endOffset": 17784,
                    "startOffset": 17779
                }
            },
            "secId": "sec0005",
            "sentence": "The decrease in MenC disease was disproportionately greater than for MenB disease due to the introduction of MenC vaccine for one-year old children in 2006 [3,4].",
            "startOffset": 17623,
            "title": "Introduction"
        },
        {
            "endOffset": 29647,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                },
                {
                    "id": "sec0055",
                    "title": "Health impact"
                }
            ],
            "secId": "sec0070",
            "sentence": "Considering direct effects only (no herd protection) 12,668 children would need to receive the vaccine to prevent a single case over a cohort's lifetime with a 2, 3, 4 + 12 months schedule.",
            "startOffset": 29458,
            "title": "Number needed to vaccinate"
        },
        {
            "endOffset": 27215,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "secId": "sec0045",
            "sentence": "Parameter uncertainty was handled through scenario analyses and by probabilistic sensitivity analyses (PSA).",
            "startOffset": 27107,
            "title": "Scenario analyses"
        },
        {
            "endOffset": 25109,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "We considered several vaccination strategies including routine infant immunisation at varying ages with or without a catch-up campaign (Table 1).",
            "startOffset": 24964,
            "title": "Model parameters"
        },
        {
            "endOffset": 30286,
            "parents": [],
            "secId": "sec0075",
            "sentence": "The predicted reduction in healthcare costs over a cohort's lifetime as a result of direct vaccine effects is \u20ac873,500 with a resulting incremental cost-effectiveness ratio (ICER) of \u20ac2.0 M per QALY gained.",
            "startOffset": 30080,
            "title": "Economic impact and cost-effectiveness"
        },
        {
            "endOffset": 34088,
            "parents": [],
            "secId": "sec0080",
            "sentence": "Both models were also sensitive to disease incidence (Appendix).",
            "startOffset": 34024,
            "title": "Sensitivity analyses"
        },
        {
            "endOffset": 18066,
            "parents": [],
            "refoffsets": {
                "bib0210": {
                    "endOffset": 18065,
                    "startOffset": 18062
                }
            },
            "secId": "sec0005",
            "sentence": "Quadrivalent MenACWY vaccination is not recommended as part of the routine vaccination programme in Germany, but is recommended for those at increased risk after individual risk assessment, such as household contacts of cases, laboratory workers and immunocompromised persons [5].",
            "startOffset": 17786,
            "title": "Introduction"
        },
        {
            "endOffset": 28976,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                },
                {
                    "id": "sec0055",
                    "title": "Health impact"
                }
            ],
            "secId": "sec0065",
            "sentence": "When considering routine infant vaccination alone, strategies starting earlier in life remained most favourable in reducing cases.",
            "startOffset": 28846,
            "title": "Dynamic transmission model: incorporating herd effects following vaccination"
        },
        {
            "endOffset": 41766,
            "parents": [],
            "secId": "sec0110",
            "sentence": "HC's work was supported by the National Institute for Health Research [RDA/03/07/014 and PDF-2012-05-245].",
            "startOffset": 41660,
            "title": "Conclusions"
        },
        {
            "endOffset": 31049,
            "parents": [],
            "secId": "sec0075",
            "sentence": "The lowest ICERs in this context are produced by strategies with routine adolescent immunisation (Table 3), due to the reduced dosing schedule and therefore lower costs for vaccination, and consistent targeting of those with high meningococcal carriage prevalence.",
            "startOffset": 30785,
            "title": "Economic impact and cost-effectiveness"
        },
        {
            "endOffset": 20169,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "secId": "sec0015",
            "sentence": "Upon disease, quality of life losses for the acute episode were included.",
            "startOffset": 20096,
            "title": "Models"
        },
        {
            "endOffset": 28186,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                },
                {
                    "id": "sec0055",
                    "title": "Health impact"
                }
            ],
            "secId": "sec0060",
            "sentence": "Assuming 65% vaccine uptake and 82% strain coverage, vaccinating infants with a 2, 3, 4 + 12 months schedule is estimated to avert 34 (15%) of these cases and 3 deaths, with a similar number prevented under a 2, 4, 6 + 12 months programme (Fig. 1).",
            "startOffset": 27938,
            "title": "Cohort model: direct effects (no vaccine effects on carriage)"
        },
        {
            "endOffset": 25243,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "In the dynamic model we investigated routine adolescent vaccination (12 year olds) alone, or in combination with an infant programme.",
            "startOffset": 25110,
            "title": "Model parameters"
        },
        {
            "endOffset": 24964,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "We assumed that all cases with an amputation would result in a 50% work loss over their lifetime, either for a parent or for themselves at a later time.",
            "startOffset": 24812,
            "title": "Model parameters"
        },
        {
            "endOffset": 25366,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "Vaccination uptake was estimated based on the uptake of other vaccines with similar age-specific schedules in current use.",
            "startOffset": 25244,
            "title": "Model parameters"
        },
        {
            "endOffset": 34338,
            "parents": [],
            "secId": "sec0080",
            "sentence": "From the societal perspective ICERs were lower, but remained over one million Euros per QALY gained even when allowing for herd effects (Appendix).",
            "startOffset": 34191,
            "title": "Sensitivity analyses"
        },
        {
            "endOffset": 34594,
            "parents": [],
            "secId": "sec0080",
            "sentence": "Reducing the cost of the vaccine considerably reduced the ICER, however the cost per QALY gained remained over \u20ac100,000 even with a vaccine price of \u20ac0 and including herd effects (up to 60% efficacy against carriage acquisition) for the infant strategies.",
            "startOffset": 34339,
            "title": "Sensitivity analyses"
        },
        {
            "endOffset": 19370,
            "parents": [],
            "refoffsets": {
                "bib0225": {
                    "endOffset": 19225,
                    "startOffset": 19222
                }
            },
            "secId": "sec0005",
            "sentence": "To support decision making in Germany we adapted the independently developed model for England [8] to the German setting to predict the potential health impact and cost-effectiveness of universal vaccination with Bexsero\u00ae against MenB disease.",
            "startOffset": 19127,
            "title": "Introduction"
        },
        {
            "endOffset": 22752,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                },
                {
                    "id": "sec0015",
                    "title": "Models"
                }
            ],
            "refoffsets": {
                "bib0235": {
                    "endOffset": 22674,
                    "startOffset": 22670
                },
                "bib0240": {
                    "endOffset": 22712,
                    "startOffset": 22708
                }
            },
            "secId": "sec0025",
            "sentence": "Transmission of meningococcal carriage was represented using a Susceptible-Infected-Susceptible (SIS) model [10] without considering co-infection [11] and using a daily time step (Appendix).",
            "startOffset": 22562,
            "title": "Dynamic model specific details"
        },
        {
            "endOffset": 35496,
            "parents": [
                {
                    "id": "sec0085",
                    "title": "Discussion"
                }
            ],
            "secId": "sec0090",
            "sentence": "Model predictions suggest that only a small proportion and low absolute number of MenB cases could be prevented each year in Germany if Bexsero\u00ae vaccination was introduced at 2, 3, 4 + 12 months and if the vaccine had no impact on carriage.",
            "startOffset": 35256,
            "title": "Principal findings"
        },
        {
            "endOffset": 42375,
            "parents": [],
            "secId": "sec0110",
            "sentence": "The NIHR had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Conflicts of interest: CLT reports receiving a consulting payment from GSK in 2013.",
            "startOffset": 42170,
            "title": "Conclusions"
        },
        {
            "endOffset": 36901,
            "parents": [
                {
                    "id": "sec0085",
                    "title": "Discussion"
                }
            ],
            "secId": "sec0095",
            "sentence": "Both payer and societal perspectives were explored.",
            "startOffset": 36850,
            "title": "Strengths and limitations"
        },
        {
            "endOffset": 22270,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                },
                {
                    "id": "sec0015",
                    "title": "Models"
                }
            ],
            "refoffsets": {
                "bib0235": {
                    "endOffset": 22192,
                    "startOffset": 22188
                },
                "bib0240": {
                    "endOffset": 22230,
                    "startOffset": 22226
                }
            },
            "secId": "sec0025",
            "sentence": "Transmission of meningococcal carriage was represented using a Susceptible-Infected-Susceptible (SIS) model [10] without considering co-infection [11] and using a daily time step (Appendix).",
            "startOffset": 22080,
            "title": "Dynamic model specific details"
        },
        {
            "endOffset": 27016,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "secId": "sec0045",
            "sentence": "Factors considered in scenario analyses included: disease incidence, population mixing, vaccination uptake, strain coverage, vaccine price, societal perspective (with and without the addition of quality of life losses for carers and costs for work loss) and discount rates.",
            "startOffset": 26743,
            "title": "Scenario analyses"
        },
        {
            "endOffset": 27489,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "secId": "sec0045",
            "sentence": "Factors considered in scenario analyses included: disease incidence, population mixing, vaccination uptake, strain coverage, vaccine price, societal perspective (with and without the addition of quality of life losses for carers and costs for work loss) and discount rates.",
            "startOffset": 27216,
            "title": "Scenario analyses"
        },
        {
            "endOffset": 22390,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                },
                {
                    "id": "sec0015",
                    "title": "Models"
                }
            ],
            "secId": "sec0025",
            "sentence": "Disease cases were generated by applying an age-specific case:carrier ratio to the number of new carriage acquisitions.",
            "startOffset": 22271,
            "title": "Dynamic model specific details"
        },
        {
            "endOffset": 34023,
            "parents": [],
            "secId": "sec0080",
            "sentence": "Altering the assumption about population mixing to one based on self-reported contacts in Germany rather than a simple structure also reduced the proportion of predicted cases averted through vaccination from 22% to 19% in the dynamic model (Appendix).",
            "startOffset": 33771,
            "title": "Sensitivity analyses"
        },
        {
            "endOffset": 24811,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "Annual support costs were included for mild sequelae (unilateral hearing loss) and severe sequelae (which included amputations, major [bilateral] hearing loss, and epilepsy).",
            "startOffset": 24637,
            "title": "Model parameters"
        },
        {
            "endOffset": 38866,
            "parents": [
                {
                    "id": "sec0085",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "bib0225": {
                    "endOffset": 38800,
                    "startOffset": 38794
                },
                "bib0330": {
                    "endOffset": 38865,
                    "startOffset": 38861
                },
                "bib0335": {
                    "endOffset": 38822,
                    "startOffset": 38818
                },
                "bib0345": {
                    "endOffset": 38849,
                    "startOffset": 38845
                },
                "bib0355": {
                    "endOffset": 38800,
                    "startOffset": 38794
                },
                "bib0360": {
                    "endOffset": 38835,
                    "startOffset": 38831
                }
            },
            "secId": "sec0100",
            "sentence": "Modelling and cost-effectiveness studies on the use of Bexsero\u00ae have been published for England [8,34], the Netherlands [30], France [35], Belgium [32] and Canada [29].",
            "startOffset": 38698,
            "title": "Comparison with other studies"
        },
        {
            "endOffset": 27107,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "secId": "sec0045",
            "sentence": "The PSA was used to characterise the uncertainty around other model parameters (Appendix).",
            "startOffset": 27017,
            "title": "Scenario analyses"
        },
        {
            "endOffset": 30784,
            "parents": [],
            "secId": "sec0075",
            "sentence": "The inclusion of herd effects makes catch-up in addition to routine infant immunisation more economically favourable than routine infant immunisation alone.",
            "startOffset": 30628,
            "title": "Economic impact and cost-effectiveness"
        },
        {
            "endOffset": 34815,
            "parents": [],
            "secId": "sec0080",
            "sentence": "Routine adolescent vaccination strategies assuming indirect protection were more economically favourable, but the vaccine would have to be priced at less than \u20ac1 a dose for the ICER to fall below \u20ac30,000 per QALY gained.",
            "startOffset": 34595,
            "title": "Sensitivity analyses"
        },
        {
            "endOffset": 33147,
            "parents": [],
            "secId": "sec0080",
            "sentence": "Of the parameters considered probabilistically in the cohort model, the incremental costs of vaccination were most sensitive to the vaccine administration costs and the rates of adverse vaccine reactions; incremental QALYs gained were most sensitive to the quality of life loss utilities and to a lesser extent the proportion of people with sequelae associated with disease and long-term sequelae (Appendix).",
            "startOffset": 32739,
            "title": "Sensitivity analyses"
        },
        {
            "endOffset": 21535,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                },
                {
                    "id": "sec0015",
                    "title": "Models"
                }
            ],
            "secId": "sec0020",
            "sentence": "Single birth cohorts were considered for routine infant or toddler vaccination; multiple cohorts were considered for strategies with catch-up vaccination.",
            "startOffset": 21381,
            "title": "Cohort model specific details"
        },
        {
            "endOffset": 29884,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                },
                {
                    "id": "sec0055",
                    "title": "Health impact"
                }
            ],
            "secId": "sec0070",
            "sentence": "Assuming 30% vaccine effectiveness against carriage, this reduces to 8461 children and becomes even more favourable if older children are also vaccinated, reducing to 6373 children for the vaccination strategy 6, 8, 12 months +12 years.",
            "startOffset": 29648,
            "title": "Number needed to vaccinate"
        },
        {
            "endOffset": 33508,
            "parents": [],
            "secId": "sec0080",
            "sentence": "Increasing the strain coverage to 92% resulted in a 2% point increase in averted cases assuming direct protection only or 3% point increase allowing for herd effects.",
            "startOffset": 33342,
            "title": "Sensitivity analyses"
        },
        {
            "endOffset": 35953,
            "parents": [
                {
                    "id": "sec0085",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "bib0295": {
                    "endOffset": 35952,
                    "startOffset": 35948
                }
            },
            "secId": "sec0090",
            "sentence": "High NNVs (over 30,000) were also estimated for MenB infant vaccination in Canada [22].",
            "startOffset": 35866,
            "title": "Principal findings"
        },
        {
            "endOffset": 20323,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "secId": "sec0015",
            "sentence": "Following disease, individuals have three possible outcomes: survival without sequelae, survival with sequelae (with a reduced quality of life) or death.",
            "startOffset": 20170,
            "title": "Models"
        },
        {
            "endOffset": 37753,
            "parents": [
                {
                    "id": "sec0085",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "bib0225": {
                    "endOffset": 37752,
                    "startOffset": 37743
                },
                "bib0325": {
                    "endOffset": 37752,
                    "startOffset": 37743
                },
                "bib0330": {
                    "endOffset": 37752,
                    "startOffset": 37743
                },
                "bib0335": {
                    "endOffset": 37752,
                    "startOffset": 37743
                },
                "bib0340": {
                    "endOffset": 37752,
                    "startOffset": 37743
                },
                "bib0345": {
                    "endOffset": 37752,
                    "startOffset": 37743
                }
            },
            "secId": "sec0095",
            "sentence": "Consequently, we did not include long-term costs for mild learning disability or institutional care for patients with severe disability, making our cost estimate for severe sequelae rather conservative [8,28\u201332].",
            "startOffset": 37541,
            "title": "Strengths and limitations"
        },
        {
            "endOffset": 18190,
            "parents": [],
            "secId": "sec0005",
            "sentence": "In January 2013 Bexsero\u00ae became the first vaccine to be licensed in the EU to provide broad protection against MenB disease.",
            "startOffset": 18066,
            "title": "Introduction"
        },
        {
            "endOffset": 30627,
            "parents": [],
            "secId": "sec0075",
            "sentence": "Allowing for herd effects improves the cost-effectiveness of vaccination, however, the ICER remains over \u20ac500,000 for all considered strategies (Table 3).",
            "startOffset": 30473,
            "title": "Economic impact and cost-effectiveness"
        },
        {
            "endOffset": 30472,
            "parents": [],
            "secId": "sec0075",
            "sentence": "Assuming direct vaccine effects only, all vaccination strategies considered resulted in very high ICERs, with strategies that included catch-up being least favourable (Table 2, Fig. 2).",
            "startOffset": 30287,
            "title": "Economic impact and cost-effectiveness"
        },
        {
            "endOffset": 38927,
            "parents": [
                {
                    "id": "sec0085",
                    "title": "Discussion"
                }
            ],
            "refoffsets": {
                "bib0365": {
                    "endOffset": 38926,
                    "startOffset": 38922
                }
            },
            "secId": "sec0100",
            "sentence": "In Spain the direct health impact alone was considered [36].",
            "startOffset": 38867,
            "title": "Comparison with other studies"
        },
        {
            "endOffset": 40970,
            "parents": [
                {
                    "id": "sec0085",
                    "title": "Discussion"
                }
            ],
            "secId": "sec0105",
            "sentence": "Thus, any immunisation decision will need to balance the potential benefits of any given vaccination strategy, the likelihood of the strategy being adopted in practice, as well as potentially unfavourable effects on the uptake of other vaccines.",
            "startOffset": 40725,
            "title": "Implications for policy makers"
        },
        {
            "endOffset": 21590,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                },
                {
                    "id": "sec0015",
                    "title": "Models"
                }
            ],
            "secId": "sec0020",
            "sentence": "A Markov model with monthly cycles was used (Appendix).",
            "startOffset": 21535,
            "title": "Cohort model specific details"
        },
        {
            "endOffset": 41597,
            "parents": [],
            "secId": "sec0110",
            "sentence": "Whilst cost-effectiveness is not a central requirement for immunisation decision-making in Germany, the majority of scenarios considerably exceeded commonly used economic willingness to pay thresholds.",
            "startOffset": 41396,
            "title": "Conclusions"
        },
        {
            "endOffset": 36455,
            "parents": [
                {
                    "id": "sec0085",
                    "title": "Discussion"
                }
            ],
            "secId": "sec0090",
            "sentence": "In terms of economic impact, all modelled strategies for the use of Bexsero\u00ae vaccination in Germany were associated with ICERs over \u20ac500,000 per QALY gained under base case conditions.",
            "startOffset": 36271,
            "title": "Principal findings"
        },
        {
            "endOffset": 24321,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "Acute health care costs included the cost of: ambulance transfer; hospitalisation; hearing assessment; and public health management.",
            "startOffset": 24189,
            "title": "Model parameters"
        },
        {
            "endOffset": 23044,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                },
                {
                    "id": "sec0015",
                    "title": "Models"
                }
            ],
            "secId": "sec0025",
            "sentence": "Vaccinated individuals with immunity could have protection against carriage acquisition (initially assumed to be 30% reduction in carriage acquisition) as well as disease.",
            "startOffset": 22873,
            "title": "Dynamic model specific details"
        },
        {
            "endOffset": 24367,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "Costs due to loss of work were also included.",
            "startOffset": 24322,
            "title": "Model parameters"
        },
        {
            "endOffset": 18696,
            "parents": [],
            "secId": "sec0005",
            "sentence": "In Germany the Standing Committee on Vaccination (St\u00e4ndige Impfkommission, STIKO) is the independent advisory group whose recommendations are required for inclusion of a vaccine in the national vaccination schedule and for reimbursement by statutory health insurance.",
            "startOffset": 18429,
            "title": "Introduction"
        },
        {
            "endOffset": 20431,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "secId": "sec0015",
            "sentence": "Those dying from the disease are assumed to lose the average life expectancy for the age at which they die.",
            "startOffset": 20324,
            "title": "Models"
        },
        {
            "endOffset": 32738,
            "parents": [],
            "secId": "sec0080",
            "sentence": "Routine adolescent vaccination strategies assuming indirect protection were more economically favourable, but the vaccine would have to be priced at less than \u20ac1 a dose for the ICER to fall below \u20ac30,000 per QALY gained.",
            "startOffset": 32518,
            "title": "Sensitivity analyses"
        },
        {
            "endOffset": 19127,
            "parents": [],
            "secId": "sec0005",
            "sentence": "Modelling the potential impact of a new vaccine on disease burden provides valuable evidence to STIKO and while assessment of the cost-effectiveness of a new vaccine is not obligatory for development of a STIKO recommendation, results are valuable for deciding on an overall immunisation strategy.",
            "startOffset": 18830,
            "title": "Introduction"
        },
        {
            "endOffset": 20590,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "secId": "sec0015",
            "sentence": "Individuals may die from other causes; published mortality rates were adjusted to remove deaths due to meningococcal disease as these are explicitly modelled.",
            "startOffset": 20432,
            "title": "Models"
        },
        {
            "endOffset": 19774,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "bib0225": {
                    "endOffset": 19773,
                    "startOffset": 19770
                }
            },
            "secId": "sec0015",
            "sentence": "These models are described fully elsewhere [8].",
            "startOffset": 19727,
            "title": "Models"
        },
        {
            "endOffset": 26417,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "bib0285": {
                    "endOffset": 26416,
                    "startOffset": 26412
                }
            },
            "secId": "sec0040",
            "sentence": "All costs were measured in Euros at 2013 prices, with previous costs adjusted based on the German consumer price index [20].",
            "startOffset": 26293,
            "title": "Cost-effectiveness analyses"
        },
        {
            "endOffset": 21768,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                },
                {
                    "id": "sec0015",
                    "title": "Models"
                }
            ],
            "secId": "sec0020",
            "sentence": "Disease cases were generated through applying the age-specific probability of disease to the susceptible population; survivors of disease were removed from the susceptible pool.",
            "startOffset": 21591,
            "title": "Cohort model specific details"
        },
        {
            "endOffset": 31264,
            "parents": [],
            "secId": "sec0080",
            "sentence": "Increasing vaccine uptake in infants from 65% to 70% resulted in an estimated 1% point increase in cases averted assuming direct protection only or 2% point increase when including herd effects.",
            "startOffset": 31070,
            "title": "Sensitivity analyses"
        },
        {
            "endOffset": 31946,
            "parents": [],
            "secId": "sec0080",
            "sentence": "Altering the assumption about population mixing to one based on self-reported contacts in Germany rather than a simple structure also reduced the proportion of predicted cases averted through vaccination from 22% to 19% in the dynamic model (Appendix).",
            "startOffset": 31694,
            "title": "Sensitivity analyses"
        },
        {
            "endOffset": 27804,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                },
                {
                    "id": "sec0055",
                    "title": "Health impact"
                }
            ],
            "secId": "sec0060",
            "sentence": "Table 2 shows the predicted impact of vaccination in birth cohorts (663,026 individuals in a single birth cohort) over their lifetime.",
            "startOffset": 27670,
            "title": "Cohort model: direct effects (no vaccine effects on carriage)"
        },
        {
            "endOffset": 41160,
            "parents": [],
            "secId": "sec0110",
            "sentence": "Given the current very low incidence of MenB disease in Germany, implementation of universal infant vaccination with Bexsero\u00ae would prevent only a small absolute number of cases.",
            "startOffset": 40982,
            "title": "Conclusions"
        },
        {
            "endOffset": 23846,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "secId": "sec0030",
            "sentence": "Each case was assumed to be hospitalised, with 48% requiring ambulance transfer.",
            "startOffset": 23766,
            "title": "Model parameters"
        },
        {
            "endOffset": 37100,
            "parents": [
                {
                    "id": "sec0085",
                    "title": "Discussion"
                }
            ],
            "secId": "sec0095",
            "sentence": "There is considerable uncertainty in some of the parameters used in the models and this was addressed using a partial probabilistic approach in the cohort model and scenario analyses in both models.",
            "startOffset": 36902,
            "title": "Strengths and limitations"
        },
        {
            "endOffset": 37540,
            "parents": [
                {
                    "id": "sec0085",
                    "title": "Discussion"
                }
            ],
            "secId": "sec0095",
            "sentence": "There were limited available data on the incidence and costs associated with long term sequelae in Germany.",
            "startOffset": 37433,
            "title": "Strengths and limitations"
        },
        {
            "endOffset": 26135,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "secId": "sec0035",
            "sentence": "We calculated the number needed to vaccinate (NNV) to prevent one case by dividing the number of persons vaccinated by the number of cases averted under various model assumptions.",
            "startOffset": 25956,
            "title": "Effectiveness analyses"
        },
        {
            "endOffset": 27580,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "secId": "sec0045",
            "sentence": "The PSA was used to characterise the uncertainty around other model parameters (Appendix).",
            "startOffset": 27490,
            "title": "Scenario analyses"
        },
        {
            "endOffset": 17077,
            "parents": [],
            "secId": "sec0005",
            "sentence": "In Germany, an average of 243 cases and 20 deaths of invasive meningococcal disease (IMD) due to serogroup B (MenB) were reported to the Robert Koch Institute (RKI) each year between 2009 and 2012 (statutory surveillance data, RKI, personal communication).",
            "startOffset": 16821,
            "title": "Introduction"
        },
        {
            "endOffset": 21890,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                },
                {
                    "id": "sec0015",
                    "title": "Models"
                }
            ],
            "secId": "sec0020",
            "sentence": "Cohort sizes were based upon 2011 population statistics.",
            "startOffset": 21834,
            "title": "Cohort model specific details"
        },
        {
            "endOffset": 26614,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "bib0290": {
                    "endOffset": 26554,
                    "startOffset": 26550
                }
            },
            "secId": "sec0040",
            "sentence": "In the base case, future costs and benefits were discounted back to their present value at a rate of 3.0% as recommended in Germany [21] and the analysis was undertaken from the payer perspective.",
            "startOffset": 26418,
            "title": "Cost-effectiveness analyses"
        },
        {
            "endOffset": 28362,
            "parents": [
                {
                    "id": "sec0050",
                    "title": "Results"
                },
                {
                    "id": "sec0055",
                    "title": "Health impact"
                }
            ],
            "secId": "sec0060",
            "sentence": "Vaccination at 6, 8, 12 months of age averted 25 cases as the assumed increased duration of protection does not compensate for missing the cases that occur before vaccination.",
            "startOffset": 28187,
            "title": "Cohort model: direct effects (no vaccine effects on carriage)"
        },
        {
            "endOffset": 42461,
            "parents": [],
            "secId": "sec0110",
            "sentence": "HC reports receiving an honoraria, paid to her employer, from Sanofi Pasteur in 2015.",
            "startOffset": 42376,
            "title": "Conclusions"
        },
        {
            "endOffset": 21380,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                },
                {
                    "id": "sec0015",
                    "title": "Models"
                }
            ],
            "secId": "sec0020",
            "sentence": "Cohort sizes were based upon 2011 population statistics.",
            "startOffset": 21324,
            "title": "Cohort model specific details"
        },
        {
            "endOffset": 30079,
            "parents": [],
            "secId": "sec0075",
            "sentence": "At a vaccine price per dose of \u20ac96.96 vaccination of infants at 2, 3, 4 + 12 months within the cohort model is expected to cost \u20ac191.9 M annually (Table 2).",
            "startOffset": 29923,
            "title": "Economic impact and cost-effectiveness"
        },
        {
            "endOffset": 37891,
            "parents": [
                {
                    "id": "sec0085",
                    "title": "Discussion"
                }
            ],
            "secId": "sec0095",
            "sentence": "We did include costs for rehabilitation, physical therapy, and speech therapy in the year after illness for a proportion of the patients.",
            "startOffset": 37754,
            "title": "Strengths and limitations"
        },
        {
            "endOffset": 19726,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "bib0230": {
                    "endOffset": 19554,
                    "startOffset": 19551
                }
            },
            "secId": "sec0015",
            "sentence": "We used two models to estimate the potential impact of universal Bexsero\u00ae vaccination in Germany due to the uncertainty about the effect of the vaccine on carriage [9]: a cohort model allowing for direct vaccine protection against disease only, and a dynamic transmission model that includes additional vaccine protection against carriage.",
            "startOffset": 19387,
            "title": "Models"
        },
        {
            "endOffset": 23766,
            "parents": [
                {
                    "id": "sec0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "bib0245": {
                    "endOffset": 23765,
                    "startOffset": 23761
                }
            },
            "secId": "sec0030",
            "sentence": "For the dynamic model MenB carriage prevalence estimates were based on a systematic review of all serogroup carriage combined with serogroup specific information from a carriage study in Germany [12].",
            "startOffset": 23566,
            "title": "Model parameters"
        }
    ],
    "docId": "S0264410X16301244",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "Hannah.christensen@bristol.ac.uk",
                "first": "Hannah",
                "initial": "H.",
                "last": "Christensen"
            },
            {
                "email": "tom.j.irving@gmail.com",
                "first": "Tom",
                "initial": "T.",
                "last": "Irving"
            },
            {
                "email": "KochJ@rki.de",
                "first": "Judith",
                "initial": "J.",
                "last": "Koch"
            },
            {
                "email": "clt56@cam.ac.uk",
                "first": "Caroline L.",
                "initial": "C.L.",
                "last": "Trotter"
            },
            {
                "email": "UltschB@rki.de",
                "first": "Bernhard",
                "initial": "B.",
                "last": "Ultsch"
            },
            {
                "email": "WeidemannF@rki.de",
                "first": "Felix",
                "initial": "F.",
                "last": "Weidemann"
            },
            {
                "email": "WichmannO@rki.de",
                "first": "Ole",
                "initial": "O.",
                "last": "Wichmann"
            },
            {
                "email": "HellenbrandW@rki.de",
                "first": "Wiebke",
                "initial": "W.",
                "last": "Hellenbrand"
            }
        ],
        "doi": "10.1016/j.vaccine.2016.04.004",
        "firstpage": "3412",
        "issn": "0264410X",
        "keywords": [
            "Cost-effectiveness",
            "Meningococcal disease",
            "Model",
            "Serogroup B"
        ],
        "lastpage": "3419",
        "openaccess": "Full",
        "pub_year": 2016,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Epidemiological impact and cost-effectiveness of universal vaccination with Bexsero\u00ae to reduce meningococcal group B disease in Germany"
    }
}